Windlas Biotech has announced a share buyback via a tender offer for up to 4.70 lakh shares at ₹1,000 per share.

The total buyback size is ₹47 Cr.

Tendering for the buyback opens on April 30, 2026, and closes on May 07, 2026 (excluding May 01, 2026 due to a SEBI holiday). Promoters do not intend to participate.

Post-buyback (assuming full acceptance), promoter shareholding is projected to increase to 63.31% from 61.90%, while public shareholding will adjust to 36.69%. The company anticipates an improvement in EPS and Return on Equity, with the debt-to-equity ratio remaining compliant.